Search clinical trials for: SPD476 (1.2g)

Total 278 results

Shire

Completed

Prevention of Recurrence of Diverticulitis (PREVENT1)

Diverticulitis

New Zealand, United States, United Kingdom, Sweden, Australia, Israel, India, Spain, Colombia, Argentina, France
Novartis Pharmaceuticals

Completed

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Subacute Cutaneous Lupus Erythematosus

Greece, Germany, Italy
Shire

Completed

Prevention of Recurrence of Diverticulitis (PREVENT2)

Diverticulitis

United States, Italy, Germany, Canada, Brazil, Romania, Netherlands, Finland, South Africa, Hungary
Hanlim Pharm. Co., Ltd.

Completed

A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) (HL301)

Acute Exacerbations of Chronic Bronchitis | Acute Bronchitis

Korea, Republic of
Shire

Withdrawn

A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators

Attention Deficit Hyperactivity Disorder

United States
Shire

Completed

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Seoul National University Hospital

Unknown

Mannitol Brain Relaxation Effect (MANNITOL)

Supratentorial Neoplasms

Korea, Republic of
University of California, Los Angeles

Completed

Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora (XOS)

Healthy Volunteers | Bifidobacteria

United States
Boston Scientific Corporation

Completed

Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter

Coronary Artery Disease

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.

Smoking

Poland
BrainQ Technologies Ltd.
Sheba Medical Center; The Miami Project to Cure Paralysis; Kessler Institute...

Recruiting

The Use of Electromagnetic Field (EMF) Treatment in Chronic Spinal Cord Injury (SCI) Patients

Incomplete Spinal Cord Injury

Israel, United States
University Hospital, Caen

Unknown

THE INFLUENCE OF GRAVITY (ARGuide)

Healthy Volunteers

France
U.S. Army Medical Research and Development Command

Completed

mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms (BIMA)

Post-Concussion Syndrome | Traumatic Brain Injury With Brief Loss of Consciousness

United States
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Department of Health and Human Services

Completed

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States, Zimbabwe, Kenya, South Africa
Bayer

Completed

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Heart Failure

Belgium, France, Switzerland, United States, Spain, Greece, Japan, Singapore, Austria, Germany, Korea, Republic of, Poland, Denmark, Israel, Netherlands, Taiwan, Bulgaria, Canada, Sweden, Czechia, Australia, Italy, Hungary, United Kingdom
Abbott Medical Devices

Completed

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions (CROSS)

Ischemic Heart Disease | Coronary Artery Stenosis | Coronary Bypass Graft Stenosis | Chronic Coronary Total Occlusion

United States
Bayer

Completed

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)

Heart Failure

Belgium, France, Spain, Greece, Portugal, Japan, United States, Singapore, Austria, Germany, Korea, Republic of, Poland, Australia, Israel, Netherlands, Switzerland, Taiwan, Bulgaria, Canada, Czechia, Denmark, Hungary, Italy, Sweden, United...
University of Illinois at Urbana-Champaign

Completed

Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women

Aging

United States
Shire

Completed

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Chile, Australia, Argentina, United Kingdom
Shire

Completed

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

Colitis, Ulcerative
Shire

Terminated

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

Schizophrenia

United States
Waterstone Pharmaceutical (Wuhan) Co., LTD.

Recruiting

A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.

Hyperkalemia

China
Tongji Hospital

Unknown

Application Study of 12G Pigtail Catheter Used for Post-operative Drainage After Thoracoscopic Surgery for Mediastinal Nodes

Mediastinal Nodes
University Hospitals Bristol and Weston NHS Foundation...

Unknown

Does a Ketogenic Diet Causes Ketosis in Patients on Intensive Care?

Ketosis
Shire

Completed

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Ulcerative Colitis

United States, United Kingdom, Australia, Poland, Slovakia
B. Braun Medical Inc.
Parexel

Completed

Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX (2 Cef)

Infection

United States
The Hospital for Sick Children

Completed

Nitrogen Balance in Infants After Post Cardiothoracic Surgery

Congenital Heart Disease

Canada
Shire

Completed

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

Sleep Deprivation

United States
Mahidol University

Not yet recruiting

Effect of Using Dextrose-containing Intraoperative Fluid in Children

Pediatric Surgery

Thailand
Recep Tayyip Erdogan University Training and Research...

Completed

Effect of Vitamin D on Periodontal Disease

Periodontal Diseases | Vitamin D Deficiency

Turkey
Columbia University
Abbott Nutrition

Completed

Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings

Critical Illness | Enteral Feeding

United States
Oregon Health and Science University
Medical Research Foundation, Oregon

Completed

Acupuncture for Sedation in the Intensive Care Unit (ICU)

Delirium | Respiratory Depression | Overmedication

United States
Shire

Completed

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Spain, Denmark, Korea, Republic of, Australia, Taiwan, Singapore, Sweden, Belgium, France, United Kingdom, Romania, New Zealand, India, Canada, South Africa, Brazil, Germany, Mexico, Hungary, Portugal, Chile, Netherlands and more
Shire

Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Nobelpharma

Terminated

A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

Neurofibromatosis

Japan
Nobelpharma

Completed

Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

Plaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic Macule

Japan
Beijing Dongfang Biotech Co., Ltd.

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Type2 Diabetes Mellitus

China
Nobelpharma

Completed

Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)

Plaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic Macule

Japan
Shire

Completed

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Schizophrenia and Predominant Negative Symptoms

United States
Sheffield Hallam University

Unknown

Mod of Cognitive Flexibility by tDCS, Tyrosine Polymorphisms in the COMT Gene

Modulation of Cognitive Flexibility by Transcranial Direct Current Stimulation, Tyrosine Administration and Polymorphisms in the COMT Gene

United Kingdom
Erasmus Medical Center
Ludwig-Maximilians - University of Munich; University Medicine Greifswald; Academisch... and other collaborators

Completed

Povidone-iodine Antisepsis for Strabismus Surgery (PASS)

Surgery | Strabismus | Endophthalmitis

Netherlands, Germany
Haramaya Unversity

Completed

Acceptability and Effectiveness of Household Water Treatment in Reducing Diarrhea Among Under Five Children

Acute Diarrhoea

Ethiopia
Shire

Completed

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

Essential Thrombocythemia (ET)

Japan
Shire

Completed

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Colitis, Ulcerative

Belgium
University of Michigan

Completed

Study of the Safety of KSP Heptapeptide (KSP-910638G)

Healthy Adults

United States
Government Dental College and Research Institute...

Completed

1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis

Chronic Periodontitis
Shire

Withdrawn

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia (NSS)

Negative Symptoms of Schizophrenia
China Medical University Hospital

Terminated

Clinical Evaluation of Acupuncture on the Complications of Cerebral Vascular Accident

Stroke

Taiwan
Seton Healthcare Family

Completed

Efficacy of Tyrosine in Restless Legs Syndrome

Restless Legs Syndrome (RLS)

United States
Shire

Completed

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium

Search clinical trials for: SPD476 (1.2g)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations